- ICUI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
ICU Medical (ICUI) S-3ASRAutomatic shelf registration
Filed: 3 Mar 23, 5:11pm
Exhibit 5.1
650 Town Center Drive, 20th Floor Costa Mesa, California 92626-1925 Tel: +1.714.540.1235 Fax: +1.714.755.8290 www.lw.com | ||||||
![]() | FIRM / AFFILIATE OFFICES | |||||
Austin |
Milan | |||||
Beijing | Munich | |||||
Boston | New York | |||||
Brussels | Orange County | |||||
Century City | Paris | |||||
Chicago | Riyadh | |||||
Dubai | San Diego | |||||
Düsseldorf | San Francisco | |||||
Frankfurt | Seoul | |||||
Hamburg | Shanghai | |||||
March 3, 2023 | Hong Kong | Silicon Valley | ||||
Houston | Singapore | |||||
London | Tel Aviv | |||||
Los Angeles | Tokyo | |||||
ICU Medical, Inc. | Madrid | Washington, D.C. |
951 Calle Amanecer
San Clemente, California 92673
Re: | Registration Statement on Form S-3; 2,500,000 shares of common stock, par value $0.10 per share |
To the addressee set forth above:
We have acted as special counsel to ICU Medical, Inc., a Delaware corporation (the “Company”), in connection with the proposed offer and sale of up to 2,500,000 shares (the “Shares”) of the Company’s common stock, par value $0.10 per share, by the selling stockholder named in the Registration Statement (as defined below). The Shares are included in a registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on March 3, 2023 (the “Registration Statement”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus (the “Prospectus”), other than as expressly stated herein with respect to the issue of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware, and we express no opinion with respect to any other laws.
Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof the Shares have been duly authorized by all necessary corporate action of the Company, and are validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company complied with all applicable notice requirements regarding uncertificated shares provided in the General Corporation Law of the State of Delaware. This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable
March 3, 2023
Page 2
provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference to our firm in the Prospectus under the heading “Legal Matters.” In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.
Sincerely, |
/s/ Latham & Watkins LLP |